Fauci Files dump: Uganda funding trail, exposed?
The July 2026 Senate tranche of Fauci records, released under Senator Rand Paul, puts a single April 18 diary entry from Rakai, Uganda, on the record. The passage names NIAID funding and three universities on one long-running HIV project. The question that follows is simple: who paid for the early work, and how much did anyone outside the partnership actually know?
Diary page in the record
The entry appears in the diary package that accompanied the July release. It lists a visit to Rakai on April 18 with Jack Killen, led on the ground by Nelson Sewankambo, David Serwadda, T Lutalo, and F. Wabwire. The text states plainly that NIAID funds a project in the Rakai district in collaboration with Makerere University, Columbia University, and Johns Hopkins.
Researchers who have been tracing the first field sites for HIV work in Uganda now have a dated anchor. The note also describes the broader lack of basic health infrastructure, which the entry says prompted the push to use AIDS-drug enthusiasm as leverage for wider improvements.
The passage does not list grant numbers, payment schedules, or subcontracts. It does not clarify whether the universities received funds directly or through subcontracts. Those details remain outside this particular document.
Named partners on the ground
Four Ugandan researchers are listed as leading the day’s trip. Their institutions are not named in the entry, but the surrounding text links the effort to Makerere University. Columbia and Johns Hopkins appear only as named collaborators, without further detail on roles or budgets.
Jack Killen is identified as traveling with Fauci for the entire trip. No title or agency affiliation is given in the passage itself. The entry treats his presence as routine, not as a separate funding line.
Local health-care conditions are described in the same block of text. The note records that patients often could not afford basic tests, that ELISA tests for HIV cost four dollars, and that tuberculosis was the dominant opportunistic infection observed that day.
Funding line left open
The diary states that NIAID funds the Rakai project, yet the mechanism is not spelled out. No contract vehicle, no co-funding percentages, and no mention of private or foreign-government contributions appear on the page.
The text does note that even relatively wealthy patients pay out of pocket for diagnostics and drugs, while poorer patients receive limited cost-shared care. That observation sits beside the funding statement but does not connect the two.
Without the actual grant file or budget sheets, readers cannot tell whether the NIAID money covered salaries, lab reagents, patient care, or all three. The diary supplies the existence of the line, not its size or terms.
Project described as long-running
The entry calls the Rakai work a long-running project that has already produced major papers. No start date is given, and no list of publications is attached in the released materials.
The note frames the visit as one of the highlights of the trip, suggesting the site was already established before April 18. How many years earlier the collaboration began is not recorded here.
Subsequent Senate releases may contain earlier or later diary pages that bracket the timeline. This tranche supplies only the single dated stop.
Health-care gap noted on site
The same paragraph records that even the best-equipped Ugandan hospitals had limited diagnostic capacity and almost no treatment options outside the AIDS-drug pipeline. The writer concludes that AIDS funding should be used to build basic infrastructure.
The observation is presented as a policy conclusion drawn from the day’s visit, not as a funding request. No dollar amounts or agency commitments are attached to the idea in the released text.
Whether that infrastructure push ever materialized as a separate budget line is outside the scope of this single diary page. The entry stops at the recommendation.
Universities listed without roles
Makerere, Columbia, and Johns Hopkins are named in one sentence. The text does not assign tasks, budgets, or oversight duties to any of them.
Academic partnerships of this kind often involve data sharing, sample collection, or training programs. None of those elements are confirmed or ruled out by the diary entry.
Absent the actual agreements or progress reports, the three names function only as a roster. Their operational footprints remain to be documented elsewhere.
Document release context
The July 2026 tranche is one of several scheduled releases from the Senate office. Earlier batches focused on anthrax communications and vaccine timelines; this batch includes the diary pages that contain the Rakai entry.
Committee staff have not yet released the full grant files or correspondence that would sit behind the diary note. The current release is limited to the personal schedule and the brief descriptive paragraph.
Additional tranches are expected in the coming months. Researchers tracking the money will need those later files to move from named partners to actual dollar flows.
Questions that remain
The entry establishes that NIAID money reached Rakai through an academic partnership by April 18. It does not establish how much money, through which mechanism, or for which exact activities.
It also leaves open whether the same collaboration later expanded into vaccine work or remained focused on treatment and epidemiology. The diary page supplies no forward-looking statements on that point.
Until the grant documents surface, the funding trail stops at the sentence that lists three universities and one agency. Everything beyond that sentence is still outside the released record.
Next documents to watch
Subsequent releases may include budget tables, subcontract lists, or correspondence that names the same four Ugandan researchers alongside specific dollar amounts. Those pages would turn the current roster into a ledger.
Any earlier diary entries that predate April 18 could show when the collaboration first appears in Fauci’s schedule. Later entries could show when the project’s scope changed or ended.
Until those files arrive, the April 18 Rakai note stands as the clearest public marker of NIAID involvement at that site, with the precise funding path still to be traced.
